Sante et Prevoyance
- Address
- Rue Saint-Luc 8, 5004 Namur, Belgium
Sante et Prevoyance - Hepatology Research Center
Sante et Prevoyance is a specialized medical research facility focused on advancing the understanding and treatment of chronic viral hepatitis infections. The center demonstrates particular expertise in investigating treatment strategies for chronic hepatitis B, with emphasis on optimizing therapeutic approaches and understanding viral behavior in diverse patient populations.
- Nucleos(t)ide analogue treatment strategies and cessation protocols in chronic hepatitis B
- Ethnic variations in viral outcomes and treatment response
- Off-treatment viral dynamics in HBeAg negative chronic hepatitis B infection
The research center's current investigations examine controlled treatment interruption strategies, specifically studying how ethnicity contributes to post-treatment viral outcomes following cessation of nucleos(t)ide analogue therapy. This work is crucial for developing personalized treatment approaches that account for patient diversity and optimize long-term management strategies in chronic hepatitis B infections.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 16 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Az St-Jan Brugge-Oostende A.V.1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Sante et Prevoyance
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Colchicine Efficacy in Reducing Cardiovascular Events in Post-PCI Patients with Coronary Artery Disease: A Randomized, Placebo-Controlled Trial | Az St-Jan Brugge-Oostende A.V., Universitair Ziekenhuis Gent | Phase III | Recruiting | Jan 2024 | — |
IMP list
lock Showing 1 of 16 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2017-07-31 | 2017-07-31 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.